CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy
- PMID: 32012249
- DOI: 10.1002/eji.201948318
CD8+ T cells mediate ultraviolet A-induced immunomodulation in a model of extracorporeal photochemotherapy
Abstract
Extracorporeal photochemotherapy (ECP) that takes advantage of the immunomodulatory effects of UV light has been extensively used for many years for the treatment of several T cell-mediated diseases, including graft-versus-host disease (GvHD) and systemic scleroderma. Immune mechanisms that lead to the establishment of T cell tolerance in ECP-treated patients remain poorly known. In this study, we have tested the effect of UV/psoralen-treated BM-derived dendritic cells, referred to as ECP-BMDCs on the outcome of an antigen-specific T cell-mediated reaction, that is, contact hypersensitivity (CHS), which is mediated by CD8+ effector T cells (CD8+ Teff ). The intravenous (i.v.) injection of antigen-pulsed ECP-BMDCs in recipient C57BL/6 mice induced specific CD8+ T cells endowed with immunomodulatory properties (referred to as CD8+ TECP ), which prevented the priming of CD8+ Teff and the development of CHS, independently of conventional CD4+ regulatory T cells. CD8+ TECP mediated tolerance by inhibiting the migration and functions of skin DC and subsequently the priming of CD8+ Teff . CD8+ TECP displayed none of the phenotypes of the usual CD8+ T regulatory cells described so far. Our results reveal an underestimated participation of CD8+ T cells to ECP-induced immunomodulation that could explain the therapeutic effects of ECP in T cell-mediated diseases.
Keywords: CD8+ regulatory T cells; T-cell priming; extracorporeal photochemotherapy; photopheresis; regulatory T cells.
© 2020 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
References
-
- Edelson, R., Berger, C., Gasparro, F., Jegasothy, B., Heald, P., Wintroub, B., Vonderheid, E. et al., Treatment of cutaneous T cell lymphoma by extracorporeal photochemotherapy: preliminary results. N. Engl. J. Med. 1987. 316: 297-303.
-
- Martino, M., Fedele, R., Cornelio, G., Moscato, T., Imbalzano, L., Ressa, G., Massara, E. et al., Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art. Expert Opin. Biol. Ther. 2012. 12: 1017-1030.
-
- Lamioni, A., Parisi, F., Isacchi, G., Giorda, E., Di Cesare, S., Landolfo, A., Cenci, F. et al., The immunological effects of extracorporeal photopheresis unraveled: induction of tolerogenic dendritic cells in vitro and regulatory T cells in vivo. Transplantation 2005. 79: 846-850.
-
- Perruche, S., Zahng, P., Liu, Y., Saas, P., Bluestone, JA. and Chen, W. CD3-specific antibody-induced immune tolerance involves transforming growth factor-β from phagocytes digesting apoptotic T cells. Nat. Med. 2008. 14: 528-535.
-
- Biaggi, E., Di Biaso, I., Leoni, V., Gaipa, G., Rossi, V., Bugarin, C., Renoldi, G. et al., Extracorporeal photochemotherapy is accompagnied by increasing levels of circulating CD4+CD25+GITR+FoxP3+CD62L+ functional regulatory T-cells in patients with graft-versus-host disease. Transplantation 2007. 84: 31-39.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
